These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Immunomodulation by OK-432 and calcitonin gene-related peptide (CGRP) of nitric oxide synthase (NOS) and IL-1 beta gene expression and of HSV-1 pathogenicity in mouse skin Langerhans cells (LC).
    Author: Berkowitz-Balshayi C, Becker Y.
    Journal: In Vivo; 1995; 9(5):447-54. PubMed ID: 8900922.
    Abstract:
    The effect of HSV-1 infection in the epidermis on the expression of genes for nitric oxide synthase (NOS) and interleukin-1 beta (IL-1 beta), and the ability of OK-432 to alter this effect were studied. The genes for NOS and IL-1 beta are normally expressed in Langerhans cells as well as in keratinocytes. Neither administration of OK-432 nor infection with HSV-1 abrogates this gene expression. Calcitonin gene-related peptide (CGRP) can inhibit the ability of macrophages and Langerhans cells to act as antigen-presenting cells. The effect of treatment with CGRP on mouse footpads and subsequent infection with HSV-1 was studied and compared with the effects observed after treatment with a specific antagonist for CGRP. Viral DNA was detected in adrenal gland samples of mice treated with the virus only and of mice treated with either CGRP-(1-37) or its antagonist prior to injection of the virus. In spinal cord samples, viral DNA was only detected when mice were treated with the virus or the CGRP antagonist. CGRP-(1-37) at physiological concentrations does not enable HSV-1 injected into mouse footpad skin to reach tissues which are normally resistant.
    [Abstract] [Full Text] [Related] [New Search]